The ERAD pathway mediates cross talk between two control points in cholesterol synthesis: HMG CoA reductase and squalene monooxygenase
Proceedings of the National Academy of Sciences · 2026
DOI: 10.1073/pnas.2602559123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Rebecca A Faulkner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-9046. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl CoA Reductases, Cholesterol, Squalene Monooxygenase, Endoplasmic Reticulum-Associated Degradation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), HHS | NIH | National Institute of General Medical Sciences (NIGMS), American Heart Association (AHA).
Abstract (Originalsprache)
Two key enzymes, HMG CoA reductase (HMGCR) and squalene monooxygenase (SM), are subjected to distinct endoplasmic reticulum–associated degradation (ERAD) pathways to maintain cholesterol homeostasis. HMGCR catalyzes conversion of HMG CoA to mevalonate, the first rate-limiting step in cholesterol synthesis. Sterols accelerate ERAD of HMGCR by promoting its binding to Insig proteins, which recruit E3 ubiquitin ligases for ubiquitination and degradation. Downstream, SM catalyzes oxygenation of squalene, committing intermediates to sterol synthesis. Cholesterol stimulates ERAD of SM, but through an Insig-independent mechanism mediated by the E3 ligase MARCH6. Here, we report a mechanism of posttranslational regulation involving a stable complex between HMGCR and SM in sterol-deprived cells. The two enzymes physically interact within ER membranes in an Insig-independent manner, and this interaction protects both proteins from ERAD. Loss of either enzyme destabilizes the other, indicating a costabilization mechanism. These findings uncover a layer of coordination in cholesterol synthesis, suggesting HMGCR and SM function as an integrated complex to ensure synchronization of early and late steps of the pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390-9046.
- Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390-9046.
ORCID-Profile: Rebecca A Faulkner, Russell A DeBose-Boyd
Förderung
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- American Heart Association (AHA)
Zitieren
APA
Faulkner, R. A., Jo, Y., Garland-Brasher, K., & DeBose-Boyd, R. A. (2026). The ERAD pathway mediates cross talk between two control points in cholesterol synthesis: HMG CoA reductase and squalene monooxygenase. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2602559123
Vancouver
Faulkner RA, Jo Y, Garland-Brasher K, DeBose-Boyd RA. The ERAD pathway mediates cross talk between two control points in cholesterol synthesis: HMG CoA reductase and squalene monooxygenase. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2602559123
BibTeX
@article{Faulkner2026,
author = {Faulkner, Rebecca A and Jo, Youngah and Garland-Brasher, Kristina and DeBose-Boyd, Russell A},
title = {The ERAD pathway mediates cross talk between two control points in cholesterol synthesis: HMG CoA reductase and squalene monooxygenase},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
doi = {10.1073/pnas.2602559123}
}
EUVIMED